WO1999002218A1 - Dispositif pour magnetotherapie - Google Patents

Dispositif pour magnetotherapie Download PDF

Info

Publication number
WO1999002218A1
WO1999002218A1 PCT/BY1997/000007 BY9700007W WO9902218A1 WO 1999002218 A1 WO1999002218 A1 WO 1999002218A1 BY 9700007 W BY9700007 W BY 9700007W WO 9902218 A1 WO9902218 A1 WO 9902218A1
Authority
WO
WIPO (PCT)
Prior art keywords
organ
measured parameter
change
treatment
magnetic field
Prior art date
Application number
PCT/BY1997/000007
Other languages
English (en)
Inventor
Sergey Vladimirovich Pletnev
Original Assignee
Sergey Vladimirovich Pletnev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sergey Vladimirovich Pletnev filed Critical Sergey Vladimirovich Pletnev
Priority to AU45457/97A priority Critical patent/AU743327B2/en
Priority to EA199800326A priority patent/EA000494B1/ru
Priority to EP97943688A priority patent/EP0942772A1/fr
Publication of WO1999002218A1 publication Critical patent/WO1999002218A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets

Definitions

  • the present invention relates to the field of medicine and in particular to magnetotherapy of various diseases and disorders of human and other living beings.
  • the method according to the invention may be applied for therapy and prophylaxis of various diseases and disturbances.
  • the prior art discloses methods for therapeutic treatment of a human organism by means of magnetic field of high frequency electromagnetic oscillations producing a thermal effect /1/. These methods are commonly used in practice at physiotherapeutic rooms. However as they mainly use the heating effect so in some cases such methods may be counterindicated.
  • the prior art discloses methods for magnetotherapy consisting in treating various human organs by means of pulsed or variable low frequency magnetic filed while the choice of a specific magnet in the form of a catheter or solenoid, etc. depends upon the treated organ /2/. These methods provide local treatment of a specific organ but do not specify characteristics of such treatment.
  • the prior art discloses a magnetotherapy method /3/ for treatment of gynecological diseases wherein a biological object is irradiated by impulse magnetic low frequency field movable in time and space (similar to travelling wave) and being in coincidence with contraction of the cardiac muscle.
  • the apparatus for embodiment of the said method generates packets of pulse magnetic fields of direct current at the field generating rate per packet optimally coinciding with the cardiac contraction rate, and being synchronized with the latter, while the value of magnetic induction at each treated spot of the biological object varies from 0 up to maximum 40-60 mT sliding down to 0 again, representing thereby one of the most important therapeutic factors.
  • packets of pulse magnetic fields are discretely relocated for a distance corresponding to the interval between field axes within a packet.
  • the prior art also discloses a method /4/, similar to the said one, which is used for treatment of patients suffering from ischemic heart decease.
  • the method consists in synchronizing the travelling magnetic field to the cardiac cycle. Therapy under such methods generally is carried out in series for certain periods of time which duration is usually specified by a physician.
  • individual characteristics of an organ and an organism as a whole are not considered during the treatment procedure and thereby is lowered objectiveness of valuation of duration, number and frequency of sessions required for obtaining maximum favorable therapeutic effect.
  • the therapeutic effect may be negative.
  • the prior art discloses methods for measuring characteristics of biological organs, such as measurement of resistivity between two or more zones of a human body /5/.
  • the prior art also discloses methods for measuring impedance of biological tissues during exposure to magnetic field, e.g. a method for determining human resistance /6/.
  • This method allows to examine patients treated by magnetic field by way of measuring quasi-stationary potentials between the forehead and the hand, and by way of calculating the resistance gradient, but it does not allow to value state of health of certain organs.
  • an electromagnetic inductor of a specific shape which is predetermined by obtaining for the inductor maximum access to the selected organ, is positioned close by the organ, which organ is exposed during a certain period of time to pulse magnetic field at the impulse frequency of the magnetic field being harmonized with the biological cycle of the said organ, and in the course of the magnetotherapy procedure at least one characteristic of the tissue in the area of the said organ is measured.
  • the said method is characterized in that for a biological cycle determining the pulse frequency of magnetic field is selected a characteristic frequency response of the measured parameter to the effect of the magnetic pulse, and the therapy time is selected after obtaining a change of the measured parameter.
  • a measured parameter there may be taken any of thermometry, testing of electric impedance, tissue magnetic permeability, acoustic location or acoustic response to the magnetic effect in the area of the treated organ.
  • the method is further characterized in that the therapy session is administrated in two steps, the first preparatory step is administrated till obtaining the first change of the measured parameter, while the session is stopped at obtaining the next change of the measured parameter.
  • the first preparatory step is administrated till obtaining the first change of the measured parameter
  • the session is stopped at obtaining the next change of the measured parameter.
  • the first preparatory step is administrated up to obtaining a change of the first measured parameter, and at the further change of the other measured parameter the session is discontinued.
  • the field amplitude is gradually reduced in order to eliminate the possible depressing effect of overdosing magnetic field.
  • the frequency of pulse rate may be selected on basis of analysis of quasi- periodical signals.
  • the analysis may be made according to the technique disclosed in /7/.
  • FIG. 1 and 2 illustrate an example of the embodiment of the method under invention.
  • Figure 1 shows a diagram of therapy and changes of parameters obtained in the course of treatment of prostate diseases.
  • Figure 2 represents a graph showing changes of the detector signal according to the [Example.
  • the organ under treatment is effected by pulse packets of magnetic filed and the packet frequency rate is adjusted with one of the biological cycles (cardiac rhythm, alpha rhythm, etc.), usually at the range 1 to 10 Hz.
  • the pulse repetition rate in the packet is selected on the bases of the measured parameter response of the organ under treatment (usually about 100Hz and above).
  • the measured signal is examined and the magnetic field amplitude is settled at the level of absence of treatment sensations (which are of the reflex nature).
  • sensations of integral character such as an orgasm during genitals therapy.
  • the present embodiment of the method uses fields at the induction 1 -10 mT producing no physiological or reflex effect but having only a stimulating effect.
  • At least one parameter is measured, and namely the parameter which is able to indicate changes happening in organ tissues.
  • the parameter which is able to indicate changes happening in organ tissues.
  • resistivity or impedance of organ tissues or tissues located immediately around it Totally this may be a temperature of an organ, though this parameter is one of the most inertial ones.
  • the most preferable parameter for measurement is registration of tissue magnetic permeability. Any of this measurements may be preformed either by means of a special detector or by a detector combined with an inductor. Studies demonstrated that therapy by magnetic field stimulates biological processes in tissues, and this is revealed in changes of electromagnetic and other parameters of organ tissues subjected to treatment. Thus, as during therapy this parameter changes, so said change allows to determine duration and intensity of the therapeutic session.
  • the first step is aimed at overcoming inertia of organ state or pathology, and the process of stimulation or normalization is expediently carried out in a more 'soft" mode. Therefore the amplitude of magnetic filed may be reduced immediately in the therapy process, especially as the subliminal treatment during stimulation is more effective and produces no side effects.
  • Measured parameters may be valuated by computer analysis of quasi- periodical signals or by the specially reserved processor. On the basis of this analysis it is possible to select parameters for therapeutic effect, such as frequency of pulse packets and pulse repetition per packet, amplitude and session duration for each step.
  • the value of the resistivity characteristic of the tissue in the area of the treated organ is measured by a detecting element made in the form of a catheter on which an even number of conductive rings is arranged, said rings are connected to commutating, registrating and analyzing devices.
  • the detector (1) is introduced through urethral canal and positioned in the immediate contact with the prostate (2).
  • the therapeutic magnetic inductor (3) (introduced rectally) is positioned in such a way that the magnetic field is directed towards prostate.
  • a change of prostate conductivity in the periods between separate impulses of therapeutic magnetic field is registered by the detector.
  • the active (resistive) and the reactive components of organ conductivity undergo changes, so variable is the value of the signal coming from the detector to the signal analyzer or to the computer.
  • Figure 2 illustrates signal variations of such a detector. Clinical tests showed that the absolute value of conductivity signals may lie within a broad dynamic range depending upon individual features and specific state of a patient.
  • the signal value may gradually vary either up or down to the absolute value. However at a certain moment the majority of patients (about 80%) demonstrate a sharp change of signal strength (section A) which change constitutes about 30% of signal strength and is easily registered by the signal analyzer. This is applied to provide individual dosing during the magnetotherapy process.
  • the signal value is stabilized in the course of further treatment by magnetic filed but at the certain moment the second signal change takes place which is also registered by the analyzer. The said second change may be identified with the beginning of the normal organ functioning.
  • An extremely sustained treatment procedure may cause degradation of the stimulating effect and change intensity of biochemical processes, and on further continued exposure to magnetic field even depression may develop. Therefore it is desirable to discontinue the therapeutic treatment by magnetic filed at the onset of normal organ functioning or in the short period after the beginning of the said functioning, which may be traced by the second change of the measured parameter.
  • the first step may be determined by one of the parameters, and the end of the second step - by the second measured parameter.
  • the criterion for determining duration of the second period may be used external demonstration of the organ functioning. Thus, recovery of erection may serve as the criterion for the described example.
  • Magnetic field parameters are selected on the basis of computer analysis of quasi-periodical signals, e.g. as disclosed in /7/.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Magnetic Treatment Devices (AREA)

Abstract

La présente invention concerne le domaine de la médecine et plus particulièrement la magnétothérapie par impulsion appliquée à des objets biologiques. Une modification d'un paramètre mesuré permet de déterminer, individuellement pour chaque patient, le moment où il convient d'administrer le traitement. La mesure d'un paramètre peut être associée conjointement ou séparément à des valeurs de paramètres physiques, par exemple, l'impédance, la perméabilité magnétique, la température, un paramètre acoustique. La fréquence d'impulsion du champ magnétique est harmonisée avec un cycle biologique de l'organe (2) traité.
PCT/BY1997/000007 1997-07-12 1997-10-07 Dispositif pour magnetotherapie WO1999002218A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU45457/97A AU743327B2 (en) 1997-07-12 1997-10-07 Device for local magnetotherapy
EA199800326A EA000494B1 (ru) 1997-07-12 1997-10-07 Способ локальной магнитотерапии
EP97943688A EP0942772A1 (fr) 1997-07-12 1997-10-07 Dispositif pour magnetotherapie

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BY971249 1997-07-12
BY971249 1997-07-12

Publications (1)

Publication Number Publication Date
WO1999002218A1 true WO1999002218A1 (fr) 1999-01-21

Family

ID=4083715

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BY1997/000007 WO1999002218A1 (fr) 1997-07-12 1997-10-07 Dispositif pour magnetotherapie

Country Status (4)

Country Link
EP (1) EP0942772A1 (fr)
AU (1) AU743327B2 (fr)
EA (1) EA000494B1 (fr)
WO (1) WO1999002218A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011045632A1 (fr) 2009-10-12 2011-04-21 Sergey Vladimirovich Pletnev Appareil de traitement et/ou prévention de maladies et de troubles fonctionnels des organes génitaux externes

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012013534B3 (de) 2012-07-05 2013-09-19 Tobias Sokolowski Vorrichtung für repetitive Nervenstimulation zum Abbau von Fettgewebe mittels induktiver Magnetfelder
US11491342B2 (en) 2015-07-01 2022-11-08 Btl Medical Solutions A.S. Magnetic stimulation methods and devices for therapeutic treatments
US10695575B1 (en) 2016-05-10 2020-06-30 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
US20180001107A1 (en) 2016-07-01 2018-01-04 Btl Holdings Limited Aesthetic method of biological structure treatment by magnetic field
US11266850B2 (en) 2015-07-01 2022-03-08 Btl Healthcare Technologies A.S. High power time varying magnetic field therapy
US11253717B2 (en) 2015-10-29 2022-02-22 Btl Healthcare Technologies A.S. Aesthetic method of biological structure treatment by magnetic field
US11464993B2 (en) 2016-05-03 2022-10-11 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US11534619B2 (en) 2016-05-10 2022-12-27 Btl Medical Solutions A.S. Aesthetic method of biological structure treatment by magnetic field
US10583287B2 (en) 2016-05-23 2020-03-10 Btl Medical Technologies S.R.O. Systems and methods for tissue treatment
US10556122B1 (en) 2016-07-01 2020-02-11 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
EP4292645A3 (fr) 2019-04-11 2024-01-31 BTL Medical Solutions a.s. Dispositifs pour le traitement esthétique de structures biologiques par radiofréquence et énergie magnétique
US11878167B2 (en) 2020-05-04 2024-01-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
BR112022022112A2 (pt) 2020-05-04 2022-12-13 Btl Healthcare Tech A S Dispositivo para tratamento não assistido do paciente
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002501A1 (fr) * 1989-08-17 1991-03-07 Mezhotraslevoi Nauchno-Tekhnichesky Komplex 'mikrokhirurgia Glaza' Dispositif de retablissement des facultes visuelles
GB2270000A (en) * 1992-08-26 1994-03-02 Robert John Grace Magnetic field induction multi - pulse therapy.
WO1996011723A1 (fr) * 1994-10-17 1996-04-25 Australasian Medical Technology Limited Methodes et dispositifs pour la mise en ×uvre d'une therapeutique fondee sur l'application de champ electromagnetique par impulsions
GB2295093A (en) * 1995-03-30 1996-05-22 Vladimir Tsebenko Synchronised electro-magnetic therapy device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002501A1 (fr) * 1989-08-17 1991-03-07 Mezhotraslevoi Nauchno-Tekhnichesky Komplex 'mikrokhirurgia Glaza' Dispositif de retablissement des facultes visuelles
GB2270000A (en) * 1992-08-26 1994-03-02 Robert John Grace Magnetic field induction multi - pulse therapy.
WO1996011723A1 (fr) * 1994-10-17 1996-04-25 Australasian Medical Technology Limited Methodes et dispositifs pour la mise en ×uvre d'une therapeutique fondee sur l'application de champ electromagnetique par impulsions
GB2295093A (en) * 1995-03-30 1996-05-22 Vladimir Tsebenko Synchronised electro-magnetic therapy device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011045632A1 (fr) 2009-10-12 2011-04-21 Sergey Vladimirovich Pletnev Appareil de traitement et/ou prévention de maladies et de troubles fonctionnels des organes génitaux externes

Also Published As

Publication number Publication date
EP0942772A1 (fr) 1999-09-22
AU743327B2 (en) 2002-01-24
EA199800326A1 (ru) 1998-10-29
AU4545797A (en) 1999-02-08
EA000494B1 (ru) 1999-08-26

Similar Documents

Publication Publication Date Title
AU743327B2 (en) Device for local magnetotherapy
Lin et al. Functional magnetic stimulation of expiratory muscles: a noninvasive and new method for restoring cough
Towe et al. A magneto-acoustic method for the noninvasive measurement of bioelectric currents
US20170113059A1 (en) Wrist worn sensor
EP2510875A3 (fr) Appareil de traitement pour appliquer des impulsions électriques au corps d'un patient
Lin Studies on microwaves in medicine and biology: From snails to humans
WO2009090440A1 (fr) Système de traitement du diabète
JPS60500521A (ja) 筋収縮、特に血管組織の不随意筋における筋収縮の刺激および制御を意図するプログラム内蔵電子装置
CN107041746B (zh) 一种用于脊柱整复系统的磁疗装置
CN107041748B (zh) 一种用于脊柱整复系统心电触发磁疗装置
RU2094069C1 (ru) Устройство для физиотерапевтического лечения заболеваний мочеполовой системы
EP0949938B1 (fr) Dispositif de magnetotherapie
Krashenyuk et al. Study of the influence of diagnostic ultrasound on the human aqua-system with bio-well device
CN106901729B (zh) 一种用于脊柱整复系统的药物涂层
CN107041749B (zh) 一种用于脊柱整复系统的皮温变色涂料
EP2021076A1 (fr) Systéme et procédé de commande du fonctionnement d'un appareil mèdical
WO2002102457A1 (fr) Dispositif destine a appliquer un champ electromagnetique au corps d'un etre vivant
RU2564753C1 (ru) Способ содействия пассажу мочи в мочеточнике
KR20190037856A (ko) 대상 부위의 생체 전위를 감소시키는 치료 장치
RU2143840C1 (ru) Способ диагностики состояния каналов из биологически активных точек, способ терапии и устройство для их осуществления
RU2314845C2 (ru) Способ терапии и диагностики и устройство для его реализации
SU1627122A1 (ru) Способ диагностической стимул ции сердца
RU2209036C2 (ru) Способ акупунктурной диагностики и лечения и устройство для его осуществления
RU2134597C1 (ru) Устройство для микроволновой терапии
RU33006U1 (ru) Электронейроадаптивный стимулятор "космодик" (варианты) и электродное устройство для электростимуляции (варианты)

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 199800326

Country of ref document: EA

AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU AZ BA BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KG KP KR KZ LR LS LT LU LV MD MG MK MN MX NO NZ PL PT RO RU SE SG SI SK TJ TM TR TT UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1997943688

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1997943688

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref document number: 1999507912

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997943688

Country of ref document: EP